Analyst raised the price target for Verona Pharma to $160.
1 report, 0 independent
Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst raised the price target for Verona Pharma to $160.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Verona Pharma
company in London, United Kingdom
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet